Orozco-Cordoba J, Mazas C, Du Pont G, Lamoyi E, Cárdenas G. FIERRO NA.
Viral biology and immune privilege in the development of extrahepatic manifestations during hepatitis E virus infection.
Viral Immunol; 2023. 36(10):627. F.I: 2.2
2023
FIERRO NA, Torres-Flores J, Mirazo S.
COVID-19 therapy: From lung disease to systemic disorder.
Curr Opin Pharmacol; 65:102246. F.I: 5.547
2022
Cervantes-Torres J, Rosales-Mendoza S, Cabello C, Montero L, Hernandez-Aceves J, Granados G, Calderón-Gallegos A, Zúñiga-Flores F, Ruiz-Rivera M, Abarca-Magaña JC, Ortega-Francisco S, Olguin-Alor R, Díaz G, Paczka-Garcia F, Zavala-Gaytan R, Vázquez-Ramírez R, Ayón-Nuñez DA, Carrero JC, Rios D, Jasso-Ramírez M, Vázquez-Hernández R, Venegas D, Garzón D, Cobos L, Segura-Velázquez R, Villalobos N, Meneses G, Zúñiga J, Gamba G, Cárdenas G, Hernández M, Parkhouse ME, Romano MC, Alonso Herrera L, Bobes RJ, Pérez-Tapia M, Huerta L, FIERRO N, Gracia I, Soldevilla G, Fragoso G, Suárez-Güemes F, Laclette JP, Sciutto E.
Towards the development of an epitope-focused vaccine for SARS-CoV-2; Vaccine.
40(45):6489. F.I: 4.169
2022
Anaya-Covarrubias JY, Pizuorno A, Mirazo S, Torres-Flores J, Du Pont G, Lamoyi E, FIERRO NA.
COVID-19 in Latin America and the caribbean region: Symptoms and morbidities in the epidemiology of the infection.
Curr Opin Pharmaco; 63:102203. F.I: 5.547
2022
Uribe M, Panduro A, DuPont G, FIERRO NA.
Clues to decipher the origin of severe acute hepatitis in children: a new enigma during the COVID-19 pandemic.
Annals Hepato;27(4)100731. F.I. 2.400
2022
FIERRO NA, Rivera-Toledo E, Avila-Horta F, Anaya-Covarrubias JY, Mendlovic F.
Scavenger receptors in the pathogenesis of viral infections.
Viral Immunol; 35(3):175. F.I: 2.257
2022
Ayón-Núñez DA, Cervantes-Torres J, Cabello-Gutiérrez C, Rosales-Mendoza S, Rios-Valencia D, Huerta L, Bobes RJ, Carrero JC, Segura- Velázquez R, FIERRO NA, Hernández M, Zúñiga-Ramos J, Gamba G, Cárdenas G, Frias-Juménez E, Herrera LA, Fragoso G, Sciutto E, Suárez-Gúemes F, Laclette JP.
An RBD-based diagnostic method useful for the surveillance of protective immunity against SARS-CoV-2 in the population.
Diagnostics; 12(7):1629. F.I: 3.992
2022
Panduro A, Roman S, FIERRO NA, Rebello-Pinho JR.
Viral kinetics of an endemic hepatitis B virus (HBV) of America: HBV subgenotype F1b.
Clinical liver diseases; 2022.19(2):41. F.I: 0.421 (SRJ)
2022
Cárdenas G, Chaves-Canales M, Espinosa AM, Jordán-Rios A, Anica-Malagon D, Márquez MF. Torres-Araujo L, Barajas-Campos R, Wong R, Ramirez L, Garcia E, Rodriguez M, Leyva Y, Hernandez-Ruiz J, Hernandez-mendel M, Leon-Hernandez M, Medina K, Sanchez A, Hernandez S, Zeron I, Martinez-Cuazitl A, Martinez I, Beltran E, Figueroa A, Herandez P, Aguilar RI; Murillo-Reyes D, Del Rio LR, Alfaro-Bonilla RA. Cruz J, Huerta L, FIERRO NA, Hernandez M,Pérez-Tapia M, Meneses G, Espindola-Arriaga E, Rosas G, Chinney A, Rosales S, Hernandez-Aceves J, Cervantes-torres J, Fuentes A, Olguin R, Ortega R, Basedovsky H, Romano MC, Bobes RJ, Jung H, Sodevila G, Lopez-Alvarenga J, Fragoso G, Laclette JP, Sciutto E.
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.
Trial; 23(1):148. F.I: 2.279
2022
Copado-Villagrana ED, Anaya-Covarrubias JY, Viera-Segura O, Trujillo-Ochoa JL, Panduro A, José-Abrego A, Roman S, FIERRO NA.
Spatial and temporal distribution of Hepatitis A Virus and Hepatitis E Virus among children with acute hepatitis in Mexico.
Viral Immunology; 34(9):653. F.I: 2.257
2021
Ashktorab H, Pizurono A, Oskroch G, FIERRO NA, Sherif ZA, Brim H.
COVID-19 in Latin America: Symptoms, morbidities and gastrointestinal manifestations.
Gastroenterology.160(3):938. F.I: 22.882
2021
Torres-Flores J, FIERRO NA.
Are previous viral infections importan ton the COVID-19 outcomes?
Annals of Hepatology; 25:100554
2021
Ashktorab H, Pizuorno A, FIERRO NA, Villagrana EDC, Solis MEH, Cardenas G, Alvarez D, Oskrochi G, Adeleye F, Dalivand MM, Laiyemo AO, Aduli F, Scherif ZA, Brim H.
A comprehensive meta-analysisi of COVID-19 in Latin America.
SOJ Microbio Infect Dis; 8(1):1-11
2021
Corral-Jara KF, Rosas da Silva G, FIERRO NA, Soumelis V.
Modelling the Th17 and Tregs paradigm: Implications for Cancer Immunotherapy.
Frontiers In Cell and Developmental Biology; 7(9):675099. F.I: 6.684
2021
Pizuorno A, FIERRO NA, Copado-Villagrana ED, Herrera-Solís ME; Oskrochi G, Brim H, Ashktorab H.
COVID-19 and gastrointestinal symptoms in Mexico, a systematic review: does location matter?
BMC Infect Dis; 21(1):555. F.I: 3.090
2021
Pizuorno A & FIERRO NA.
Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic
Annals of Hepatology. 22(22):100332. F.I: 2.400
2021
Viera-Segura O, Panduro A, Trujillo-Ochoa JL, Copado-Villagrana ED, Torres-Valadez R, Sepulveda-Vilegas M, Roman S, FIERRO NA.
Evidence for increased inflammatory cytokine profile in hepatitis E virus-infected patients: Implications for chronic liver disease
Viral Immunology. 33(9):600. F.I: 2.257
2020
FIERRO NA.
COVID-19 and the liver: What does we know after six months of the pandemic?.
Annals of Hepatology. 19(6):590; F.I: 2.400
2020
Abarca JC, Huerta L, FIERRO NA.
Antiretroviral therapies for Human Immunodeficiency Virus and the liver: Challenges and opportunities.
Annals of Hepatology; 19(2):21. F.I: 2.400
2020
FIERRO NA.
Is hepatitis A virus infection under control? Lessons in the application of viral sequencing for the development of vaccination schemes in emergency situations
EBiomedicine. 39:11. F.I: 8.143
2019
Huerta L, Anaya-Covarrubias JY, FIERRO NA.
Human immunodeficiency virus and the liver: The impact of coinfection with hepatoropic viruses.
Annals of Hepatology. 18(2):285. F.I: 2.400
2019
Viera-Segura O, Realpe-Quintero M, Panduro A, Roman S, Jose-Abrego A, Gonzalez-Aldaco K, Trujillo-Ochoa JL, FIERRO NA.
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico.
Annals of Hepatology. 18(4):571. F.I: 2.400
2019
Trujillo-Ochoa JL, Viera-Segura O, FIERRO NA.
Challenges in management of hepatitis A virus epidemiological transition in Mexico.
Annals of Hepatology. 18(1):14. F.I: 2.400
2019
Realpe-Quintero M, Mirazo S, Viera-Segura O, Copado-Villagrana ED, Panduro A, Roman S, FIERRO NA.
Hepatitis E virus genotype 1 and hepatitis A virus dual infection in pediatric patients with a low socioeconomic status from Mexico.
Intervirology. 61(3):105. F.I: 1.763
2018
Trujillo-Ochoa JL, Corral-Jara KF, Charles-Niño CL, Panduro A, FIERRO NA.
Conjugated bilirubin upregulates TIM-3 expression on CD4+CD25+ T cells: anti-inflammatory implications for hepatitis A virus infection.
Viral Immunology. 31:223. F.I: 2.257
2018
González-Aldaco K, Torres-Reyes LA, Ojeda-Granado C, José-Abrego A, FIERRO NA, Román S.
Immunometabolic effect of cholesterol in hepatitis C infection: implications in clinical management and antiviral therapy.
Annals of Hepatology. 2018.17:908. F.I: 2.400
2018
Realpe-Quintero M, Montalvo MC, Mirazo S, Panduro A, Roman S, Johne R, FIERRO NA.
Challenges in research and management of hepatitis E virus infection in Cuba, Mexico and, Uruguay.
Revista Panamamericana de Salud Publica. 4(42):e41. F.I: 0.539
2018
Realpe-Quintero M, Viera-Segura O, FIERRO NA.
Hepatitis E Virus: still and enigma in Mexico.
Annals of Hapatology. 17:544. F.I: 2.400
2018
Gonzalez-Aldaco K, Rebello Pinho JO, Panduro A, Martinez-Lopez E, Gleyzer K, FIERRO NA, Roman S.
High prevalence of ITPA alleles associated with ribavirin-induced hemolytic anemia among Mexican population.
Annals of Hepatology. 16(2):221-229. F.I: 2.400
2017
Realpe-Quintero M, Copado-Villagrana ED, Trujillo-Ochoa JL, Alvarez AH, Panduro A, FIERRO NA.
Cytokine Signatures Discriminate Highly Frequent Acute Hepatitis a Virus and Hepatitis E Virus Coinfections from Monoinfections in Mexican Pediatric Patients.
Pediatric Infectious Disease Journal. 36(7):689-692. F.I: 3.164
2017
Jose-Abrego A, Panduro A, FIERRO NA, Roman S.
High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status.
Journal of Medical Virology. 89(12):2149-2157. F.I: 2.327
2017
FIERRO NA, Realpe M, Meraz-Medina T, Roman S, Panduro A.
Hepatitis E virus: An ancient hidden enemy in Latin America.
World Journal of Gastroenterology. 22:2271-83. F.I: 5.742
2016
Gonzalez-Aldaco K, Rebello Pinho JR, Roman S, Gleyzer K, FIERRO NA, Oyakawa L, Ramos-Lopez O, Ferraz Santana RA, Sitnik R, Panduro A.
Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico.
PLoS One. 7:e0146258. F.I: 3.240
2016
Ramos-Lopez O, Roman S, Martinez-Lopez E, FIERRO NA, Gonzalez-Aldaco K, Jose-Abrego A, Panduro A.
CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection.
World Journal of Hepatology. 8;8(25):1067-74. F.I: 0.61
2016
Corral-Jara KF, Trujillo-Ochoa JL, Realpe M, Panduro A, Gómez-Leyva JF, Rosenstein Y, Jose-Abrego A, Roman S, FIERRO NA.
Conjugated bilirubin differentially regulates CD4+ T effector cells and T regulatory T cell function through ourside-in and inside-out mechanisms: the effect of HAV cell surface receptor and intracellular signalling.
Mediators of Inflammation. 2016:1759027. F.I: 3.549
2016
FIERRO NA, González-Aldaco K, Torres-Valadez R, Trujillo-Trujillo ME, Roman S, Trujillo-Ochoa JL, Panduro A.
Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients.
Mem Inst Oswaldo Cruz. 110:267-71 F.I: 2.368
2015
Ramos-Lopez O, Martinez-Lopez E, Fierro NA, Ojeda-Granados C, Sepulveda-Villegas M, Roman S.
Genetic variant in the CD36 gene (RS1761667) is associated with higher fat intake and high serum colesterol among the population of West Mexico.
Nutrition and Food. 5:1000353-57
2015
Trujillo-Ochoa JL, Corral-Jara KF, Escobedo-Meléndez G, Realpe M, Panduro A, Roman S, FIERRO NA.
T-helper 17-related cytokines and IgE antibodies during hepatitis A virus infection in children.
Mem Inst Oswaldo Cruz. 110:263-6. F.I: 2.368
2015
Muñoz-Espinosa LE, Trujillo-Trujillo ME, Martínez-Macías RF, Panduro A, Rivas-Estilla AM, FIERRO NA, Silvera-Linares AL, Torres-Valadez R, Cordero-Pérez P, González-Aldaco K, Chen-López CY, José-Abrego A, Zuñiga-Noriega JR, Gutiérrez-Ruiz MC, Roman S.
Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico
Annals of Hepatology. 14:642-51. F.I: 2.400
2015
Corral-Jara KF, Trujillo-Ochoa JL, Realpe M, Panduro A, Roman S, FIERRO NA.
Rethinking the immune properties of bilirubin in viral hepatitis: from bench to bedside.
Clin Transl Immunology. 4(12):e54. F.I: 6.161
2015
Ramos-Lopez O, Martinez-Lopez E, Roman S, FIERRO NA, Panduro A.
Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico.
World J Gastroenterol. 7:11552-66. F.I: 5.742
2015
Roman S, Jose-Abrego A, FIERRO NA, Escobedo-Melendez G, Ojeda-Granados C, Panduro A.
Hepatitis B virus infection in Latin America: a Genomic Medicine approach.
World J Gastroenterol. 20(23):7181-96. F.I: 5.742
2014
FIERRO NA, Aldaco-Gonzalez K, Torres-Valadez R, Martinez-Lopez E, Roman S, Panduro A.
Immunologic, metabolic and genetic factors on hepatitis C virus infection and disease outcome.
World J Gastroenterol.20(13): 3443-56. F.I: 5.742
2014
Castro-García FP, Corral-Jara KF, Escobedo-Melendez G, Sandoval-Hernandez MA, Rosenstein Y, Roman S, Panduro A, FIERRO NA.
Conjugated bilirubin affects cytokine profiles in hepatitis A virus infection by modulating STATs function.
Immunology. 143(4):578-87. F.I: 7.397
2014
Escobedo-Melendez G, Panduro A, FIERRO NA, Roman S.
High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico.
Mem Inst Oswaldo Cruz. 109(6):728-37. F.I: 2.368
2014
